An endocrinologist is the primary doctor who treats prolactinoma, a prolactin-producing tumor of the pituitary gland. In most cases, this specialist manages the condition with medication alone, and many patients never need surgery. However, depending on the tumor’s size, behavior, and effects on surrounding structures, a neurosurgeon, ophthalmologist, or other specialists may join your care team.
How Prolactinomas Are First Detected
Most people start with their primary care doctor or gynecologist. The symptoms that trigger investigation differ between men and women. Women typically notice missed or irregular periods, unexpected breast discharge (galactorrhea), or difficulty getting pregnant. Men more often present with low libido, erectile dysfunction, or gynecomastia, though these symptoms tend to be underestimated, which frequently leads to a delayed diagnosis in men.
A single blood draw measuring prolactin levels is usually the first diagnostic step. Normal prolactin sits below 25 µg/L in women and 20 µg/L in men. Anything above that range raises suspicion. Your primary care doctor will also want to rule out other causes of elevated prolactin, including certain medications, thyroid dysfunction, and kidney disease, before referring you to an endocrinologist. Once those are excluded, a gadolinium-enhanced MRI of the pituitary confirms the tumor.
The Endocrinologist: Your Main Specialist
An endocrinologist, ideally one with experience in pituitary disorders, will be the doctor you see most often. Prolactinomas are one of the few brain tumors treated primarily with medication rather than surgery. The first-line treatment is a class of drugs called dopamine agonists, which lower prolactin levels, shrink the tumor, and restore normal reproductive function in most patients.
Cabergoline is the preferred dopamine agonist because it works better and causes fewer side effects than the older alternative, bromocriptine. In a study of 455 patients, cabergoline normalized prolactin levels in 86% of all cases: 92% of those with smaller tumors (microprolactinomas) or elevated prolactin without a visible tumor, and 77% of those with larger tumors (macroprolactinomas). Even among patients who couldn’t tolerate bromocriptine, switching to cabergoline normalized prolactin in 84% of cases. Most patients start at 0.5 to 1.0 mg per week, with larger tumors generally requiring the higher dose.
Your endocrinologist monitors your prolactin levels through periodic blood tests, adjusts medication doses, checks for tumor shrinkage on follow-up MRIs, and watches for side effects. They also evaluate whether the tumor is affecting other pituitary hormones, since a large prolactinoma can compress the gland and reduce production of thyroid, adrenal, or growth hormones.
When a Neurosurgeon Gets Involved
Surgery becomes an option when medication doesn’t work well enough or causes intolerable side effects. Some patients are considered “resistant,” meaning their prolactin levels don’t come down adequately despite escalating doses. Others simply can’t tolerate the gastrointestinal or psychological side effects of dopamine agonists. In both situations, a neurosurgeon with pituitary expertise can offer transsphenoidal surgery, a minimally invasive procedure performed through the nose to reach the pituitary gland without opening the skull.
Outcomes depend on why surgery was needed. Among patients who were intolerant to medication, about 67% achieved normal prolactin levels after surgery without needing any further medication. For medication-resistant patients, the success rate was lower, around 36% achieving normal levels without drugs, though an additional 25% reached normal levels by resuming a lower dose of medication after surgery. At major pituitary centers, a neurosurgeon often works alongside an otolaryngologist (ear, nose, and throat surgeon) who assists with the nasal approach to the skull base.
The Ophthalmologist’s Role
Larger prolactinomas can grow upward and press on the optic chiasm, the crossing point of the optic nerves just above the pituitary gland. This compression typically causes a loss of peripheral vision, often starting in the outer edges of both eyes. An ophthalmologist, specifically a neuro-ophthalmologist, evaluates and monitors this.
The examination goes well beyond a standard eye check. It includes formal visual field testing, color vision assessment, pupil response evaluation, stereoscopic examination of the optic nerve, and optical coherence tomography (a scan that measures the thickness of nerve fibers at the back of the eye). These tests can detect early compression before permanent damage sets in. If your prolactinoma is a macroprolactinoma (generally over 10 mm), your care team will likely include an ophthalmologist from the start. Long-term monitoring remains important even after treatment, since delayed vision loss can signal tumor recurrence.
Neuroradiologists and Imaging
A neuroradiologist interprets the MRI scans that guide every stage of prolactinoma management. Their role is more specialized than simply reading a brain scan. They assess tumor size and shape, identify cysts or bleeding within the tumor, map the tumor’s relationship to the optic nerves, and determine whether the tumor has invaded the cavernous sinus, a critical venous structure on either side of the pituitary. Cavernous sinus invasion is evaluated using a classification system on contrast-enhanced MRI and significantly affects whether surgery can fully remove the tumor.
Prolactin levels themselves also help predict tumor size. Microprolactinomas (under 10 mm) typically produce prolactin levels between 94 and 188 µg/L, while macroprolactinomas (10 mm or larger) usually push levels above 235 µg/L. A prolactin level above 204 µg/L predicts a macroprolactinoma with about 93% accuracy. This correlation helps your care team interpret ambiguous imaging findings.
Fertility Specialists
Because excess prolactin directly suppresses the reproductive hormones that drive ovulation and sperm production, prolactinomas are one of the most common causes of hormone-related infertility in both sexes. In most cases, treating the prolactinoma itself restores fertility. Dopamine agonists normalize prolactin, which in turn restores the normal hormonal signals to the ovaries or testes.
For women planning pregnancy, the treatment plan needs extra coordination. Bromocriptine has a longer safety track record in pregnancy than cabergoline, so some endocrinologists switch to it before conception. Once pregnant, most women stop dopamine agonist therapy and are monitored for tumor growth, since the pituitary gland naturally enlarges during pregnancy. A reproductive endocrinologist may join the team when fertility doesn’t return with standard prolactinoma treatment or when assisted reproduction is needed.
Multidisciplinary Pituitary Centers
For straightforward microprolactinomas, an endocrinologist working with your primary care doctor is often sufficient. But for larger tumors, medication-resistant cases, or tumors in children and adolescents, guidelines recommend care through a multidisciplinary pituitary team. These teams typically include an endocrinologist, a neurosurgeon, a neuroradiologist, an ophthalmologist, and sometimes a radiation oncologist or oncologist for the rare aggressive prolactinoma that doesn’t respond to standard treatments.
Children and adolescents with prolactinomas specifically benefit from pituitary-specialized teams that bridge pediatric and adult expertise, since treatment decisions in younger patients carry long-term consequences for bone development, growth, and reproductive health. Pituitary apoplexy, a rare emergency caused by sudden bleeding into the tumor, also requires immediate multidisciplinary evaluation. Major academic medical centers are most likely to have these dedicated pituitary programs in place.